These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 16257281
1. Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss. Lindberg MK, Svensson J, Venken K, Chavoshi T, Andersson N, Movérare Skrtic S, Isaksson O, Vanderschueren D, Carlsten H, Ohlsson C. Bone; 2006 Jan; 38(1):85-92. PubMed ID: 16257281 [Abstract] [Full Text] [Related]
2. Biglycan deficiency interferes with ovariectomy-induced bone loss. Nielsen KL, Allen MR, Bloomfield SA, Andersen TL, Chen XD, Poulsen HS, Young MF, Heegaard AM. J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350 [Abstract] [Full Text] [Related]
3. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830 [Abstract] [Full Text] [Related]
4. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K, Yamada Y. J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680 [Abstract] [Full Text] [Related]
5. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. Lee SK, Kalinowski JF, Jacquin C, Adams DJ, Gronowicz G, Lorenzo JA. J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384 [Abstract] [Full Text] [Related]
12. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice. Kodama I, Niida S, Sanada M, Yoshiko Y, Tsuda M, Maeda N, Ohama K. J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389 [Abstract] [Full Text] [Related]
13. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. Ikeda T, Utsuyama M, Hirokawa K. J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864 [Abstract] [Full Text] [Related]
14. Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats. Miyazaki T, Matsunaga T, Miyazaki S, Hokari S, Komoda T. J Cell Biochem; 2004 Oct 15; 93(3):503-12. PubMed ID: 15372622 [Abstract] [Full Text] [Related]
15. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. Choi BK, Moon SY, Cha JH, Kim KW, Yoo YJ. J Periodontol; 2005 May 15; 76(5):813-20. PubMed ID: 15898943 [Abstract] [Full Text] [Related]
16. Turbo methanol extract inhibits bone resorption through regulation of T cell function. Balakrishnan B, Indap MM, Singh SP, Krishna CM, Chiplunkar SV. Bone; 2014 Jan 15; 58():114-25. PubMed ID: 24140785 [Abstract] [Full Text] [Related]